The Zephyr® Endobronchial Valve is an endoscopic lung volume reduction therapy that has been proven to significantly improve lung function, exercise capacity and quality of life for emphysema patients across four randomized, controlled clinical trials and in 12,000 patients worldwide.
In combination with its assessment products, it uniquely offers a prospectively proven method for predicting responders. It is also designed to be removable, preserving future treatment options for patients.
With the valves, we can treat patients who did not have any treatment options before.“
This is one of the best technologies for our end stage patient.“
In the right patient, the Zephyr is always going to be my first choice.“
Once implanted, the one-way valve prevents airflow into the diseased region, while allowing trapped air and fluids to escape.
Reducing the volume of the diseased region may allow healthier regions to expand and function more efficiently.
|Item number||Description||Airway diameter range|
|EBV-TS-4.0||Zephyr 4.0 Endobronchial Valve||4.0–7.0 mm|
|EBV-TS-4.0-LP||Zephyr 4.0-LP Endobronchial Valve||4.0–7.0 mm|
|EBV-TS-5.5||Zephyr 5.5 Endobronchial Valve||5.5–8.5 mm|
|EDC-TS-4.0||Zephyr 4.0 Endobronchial Delivery Catheter|
|EDC-TS-4.0-J||Zephyr 4.0-J Endobronchial Delivery Catheter|
|EDC-TS-5.5||Zephyr 5.5 Endobronchial Delivery Catheter|
Note: Each catheter can be used to deploy up to four valves per patient.